Biocon gets approval for use of CytoSorb to treat critical COVID-19 patients
New Delhi: Biocon Biologics has received DCGI approval for emergency use of CytoSorb to treat critical COVID-19 patients. The US Food...
New Delhi: Biocon Biologics has received DCGI approval for emergency use of CytoSorb to treat critical COVID-19 patients. The US Food...